Hands on bioprocess expertise, delivered by principals.

JaLisa joined the firm in 2020 and brings high-level manufacturing and technical operations leadership. She has more than 12 years of experience driving the development, scale-up, validation, technology transfer, and commercialization of advanced cell and gene therapy platforms. JaLisa is known for combining scientific expertise, operational excellence, and strategic leadership to solve complex manufacturing challenges, mitigate risk, and deliver transformational outcomes across the product lifecycle. She holds a Bachelor of Science in Biological Sciences from the University of Missouri Columbia, and a Master of Science in Clinical Research Management from Arizona State University.

Emma brings manufacturing science and technology expertise to upstream cell culture and bioreactor engineering engagements. Her published work spans bioreactor characterization at commercial scale, oxygen mass transfer modeling, CO2 control strategies for large molecule manufacturing, and the lactate metabolic shift in mammalian cell lines. She has also co authored peer reviewed studies on validation methodology for microbial control and process hold times. Emma's engineering grounding helps clients translate development scale processes into robust large scale manufacturing.

Luis joined the firm in 2020 and brings over two decades of biotechnology and biopharmaceutical experience. His technical depth covers upstream and downstream processing, with particular focus on monoclonal antibody cell culture and purification. Luis is grounded in the principle that quality extends beyond technical rationale into the safety and care owed to the patients and communities biologics serve. He holds a Master of Science from West Chester University of Pennsylvania.